Selected research
Industry Research
Over-the-Counter Drugs Industry Research Report 2026
Market perspective
The global Over-the-Counter Drugs market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Over-the-Counter Drugs market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Over-the-Counter Drugs market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Over-the-Counter Drugs market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Over-the-Counter Drugs include Teva Pharmaceutical Industries, Sanofi, Johnson & Johnson, Novartis, Merck, Pfizer, GlaxoSmithKline, Bayer and Sun Pharmaceutical Industries, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Over-the-Counter Drugs market in terms of revenue (US$ million) and, where applicable, service volume (K Units), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/K Units) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Over-the-Counter Drugs.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Over-the-Counter Drugs Market by Company
Teva Pharmaceutical Industries
Sanofi
Johnson & Johnson
Novartis
Merck
Pfizer
GlaxoSmithKline
Bayer
Sun Pharmaceutical Industries
Glenmark Pharmaceuticals
Cipla
Boehringer Ingelheim
Alkem Laboratories
Over-the-Counter Drugs Segment by Type
Cough, Cold and Flu Products
Weight Loss Products
Smoking Cession Aids
Dermatological Products
Sleep Aids
Vitamin & Mineral Supplements
Gastrointestinal Products
Ophthalmic Products
Analgesics & Pain Relievers
Other
Over-the-Counter Drugs Segment by Application
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Over-the-Counter Drugs Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Over-the-Counter Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Over-the-Counter Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Over-the-Counter Drugs.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Over-the-Counter Drugs companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Cough, Cold and Flu Products
- Weight Loss Products
- Smoking Cession Aids
- Dermatological Products
- Sleep Aids
- Vitamin & Mineral Supplements
- Gastrointestinal Products
- Ophthalmic Products
- Analgesics & Pain Relievers
- Other
Applications
- Hospital Pharmacies
- Online Pharmacies
- Retail Pharmacies
Companies covered
- Teva Pharmaceutical Industries
- Sanofi
- Johnson & Johnson
- Novartis
- Merck
- Pfizer
- GlaxoSmithKline
- Bayer
- Sun Pharmaceutical Industries
- Glenmark Pharmaceuticals
- Cipla
- Boehringer Ingelheim
- Alkem Laboratories
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Over-the-Counter Drugs by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 Cough, Cold and Flu Products
- 2.2.3 Weight Loss Products
- 2.2.4 Smoking Cession Aids
- 2.2.5 Dermatological Products
- 2.2.6 Sleep Aids
- 2.2.7 Vitamin & Mineral Supplements
- 2.2.8 Gastrointestinal Products
- 2.2.9 Ophthalmic Products
- 2.2.10 Analgesics & Pain Relievers
- 2.2.11 Other
- 2.3 Over-the-Counter Drugs by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Hospital Pharmacies
- 2.3.3 Online Pharmacies
- 2.3.4 Retail Pharmacies
- 2.4 Assumptions and Limitations
3 Over-the-Counter Drugs Breakdown Data by Type
- 3.1 Global Over-the-Counter Drugs Historic Market Size by Type (2021-2026)
- 3.2 Global Over-the-Counter Drugs Forecasted Market Size by Type (2027-2032)
4 Over-the-Counter Drugs Breakdown Data by Application
- 4.1 Global Over-the-Counter Drugs Historic Market Size by Application (2021-2026)
- 4.2 Global Over-the-Counter Drugs Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Over-the-Counter Drugs Market Perspective (2021-2032)
- 5.2 Global Over-the-Counter Drugs Growth Trends by Region
- 5.2.1 Global Over-the-Counter Drugs Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Over-the-Counter Drugs Historic Market Size by Region (2021-2026)
- 5.2.3 Over-the-Counter Drugs Forecasted Market Size by Region (2027-2032)
- 5.3 Over-the-Counter Drugs Market Dynamics
- 5.3.1 Over-the-Counter Drugs Industry Trends
- 5.3.2 Over-the-Counter Drugs Market Drivers
- 5.3.3 Over-the-Counter Drugs Market Challenges
- 5.3.4 Over-the-Counter Drugs Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Over-the-Counter Drugs Players by Revenue
- 6.1.1 Global Top Over-the-Counter Drugs Players by Revenue (2021-2026)
- 6.1.2 Global Over-the-Counter Drugs Revenue Market Share by Players (2021-2026)
- 6.2 Global Over-the-Counter Drugs Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Over-the-Counter Drugs Head Office and Area Served
- 6.4 Global Over-the-Counter Drugs Players, Product Type & Application
- 6.5 Global Over-the-Counter Drugs Manufacturers Established Date
- 6.6 Global Over-the-Counter Drugs Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Over-the-Counter Drugs Market Size (2021-2032)
- 7.2 North America Over-the-Counter Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Over-the-Counter Drugs Market Size by Country (2021-2026)
- 7.4 North America Over-the-Counter Drugs Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Over-the-Counter Drugs Market Size (2021-2032)
- 8.2 Europe Over-the-Counter Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Over-the-Counter Drugs Market Size by Country (2021-2026)
- 8.4 Europe Over-the-Counter Drugs Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Over-the-Counter Drugs Market Size (2021-2032)
- 9.2 Asia-Pacific Over-the-Counter Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Over-the-Counter Drugs Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Over-the-Counter Drugs Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Over-the-Counter Drugs Market Size (2021-2032)
- 10.2 South America Over-the-Counter Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Over-the-Counter Drugs Market Size by Country (2021-2026)
- 10.4 South America Over-the-Counter Drugs Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Over-the-Counter Drugs Market Size (2021-2032)
- 11.2 Middle East & Africa Over-the-Counter Drugs Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Over-the-Counter Drugs Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Over-the-Counter Drugs Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Teva Pharmaceutical Industries
- 12.1.1 Teva Pharmaceutical Industries Company Information
- 12.1.2 Teva Pharmaceutical Industries Business Overview
- 12.1.3 Teva Pharmaceutical Industries Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.1.4 Teva Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
- 12.1.5 Teva Pharmaceutical Industries Recent Developments
- 12.2 Sanofi
- 12.2.1 Sanofi Company Information
- 12.2.2 Sanofi Business Overview
- 12.2.3 Sanofi Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.2.4 Sanofi Over-the-Counter Drugs Product Portfolio
- 12.2.5 Sanofi Recent Developments
- 12.3 Johnson & Johnson
- 12.3.1 Johnson & Johnson Company Information
- 12.3.2 Johnson & Johnson Business Overview
- 12.3.3 Johnson & Johnson Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.3.4 Johnson & Johnson Over-the-Counter Drugs Product Portfolio
- 12.3.5 Johnson & Johnson Recent Developments
- 12.4 Novartis
- 12.4.1 Novartis Company Information
- 12.4.2 Novartis Business Overview
- 12.4.3 Novartis Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.4.4 Novartis Over-the-Counter Drugs Product Portfolio
- 12.4.5 Novartis Recent Developments
- 12.5 Merck
- 12.5.1 Merck Company Information
- 12.5.2 Merck Business Overview
- 12.5.3 Merck Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.5.4 Merck Over-the-Counter Drugs Product Portfolio
- 12.5.5 Merck Recent Developments
- 12.6 Pfizer
- 12.6.1 Pfizer Company Information
- 12.6.2 Pfizer Business Overview
- 12.6.3 Pfizer Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.6.4 Pfizer Over-the-Counter Drugs Product Portfolio
- 12.6.5 Pfizer Recent Developments
- 12.7 GlaxoSmithKline
- 12.7.1 GlaxoSmithKline Company Information
- 12.7.2 GlaxoSmithKline Business Overview
- 12.7.3 GlaxoSmithKline Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.7.4 GlaxoSmithKline Over-the-Counter Drugs Product Portfolio
- 12.7.5 GlaxoSmithKline Recent Developments
- 12.8 Bayer
- 12.8.1 Bayer Company Information
- 12.8.2 Bayer Business Overview
- 12.8.3 Bayer Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.8.4 Bayer Over-the-Counter Drugs Product Portfolio
- 12.8.5 Bayer Recent Developments
- 12.9 Sun Pharmaceutical Industries
- 12.9.1 Sun Pharmaceutical Industries Company Information
- 12.9.2 Sun Pharmaceutical Industries Business Overview
- 12.9.3 Sun Pharmaceutical Industries Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.9.4 Sun Pharmaceutical Industries Over-the-Counter Drugs Product Portfolio
- 12.9.5 Sun Pharmaceutical Industries Recent Developments
- 12.10 Glenmark Pharmaceuticals
- 12.10.1 Glenmark Pharmaceuticals Company Information
- 12.10.2 Glenmark Pharmaceuticals Business Overview
- 12.10.3 Glenmark Pharmaceuticals Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.10.4 Glenmark Pharmaceuticals Over-the-Counter Drugs Product Portfolio
- 12.10.5 Glenmark Pharmaceuticals Recent Developments
- 12.11 Cipla
- 12.11.1 Cipla Company Information
- 12.11.2 Cipla Business Overview
- 12.11.3 Cipla Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.11.4 Cipla Over-the-Counter Drugs Product Portfolio
- 12.11.5 Cipla Recent Developments
- 12.12 Boehringer Ingelheim
- 12.12.1 Boehringer Ingelheim Company Information
- 12.12.2 Boehringer Ingelheim Business Overview
- 12.12.3 Boehringer Ingelheim Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.12.4 Boehringer Ingelheim Over-the-Counter Drugs Product Portfolio
- 12.12.5 Boehringer Ingelheim Recent Developments
- 12.13 Alkem Laboratories
- 12.13.1 Alkem Laboratories Company Information
- 12.13.2 Alkem Laboratories Business Overview
- 12.13.3 Alkem Laboratories Revenue in Over-the-Counter Drugs Business (2021-2026)
- 12.13.4 Alkem Laboratories Over-the-Counter Drugs Product Portfolio
- 12.13.5 Alkem Laboratories Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst